Will Actos Bladder Cancer Lawsuits Provide Just Compensation for Those with Cancer?

Posted by mgudeman in , blogging, news.

Actos is a Type 2 diabetes drug that has been linked to  bladder cancer in a number of medical studies.   The linkage has been strong enough for the drug to be suspended from the  market in France and Germany, but there has just been an FDA Actos cancer warning in the United States.  The maker of Actos is conducting a multi-year  safety study; the interim results prompted the FDA’s initial safety notice  regarding Actos and the increased risk of bladder cancer.   That notice warned of increased bladder  cancer risk after taking Actos for two or more years.  The updated FDA Actos bladder cancer warning  told Actos users their risk of bladder cancer coud increase after using the  drug for just one year.   What followed  was recognition that the bladder cancer in current and former Actos users, as  well as former Actos users who had died of bladder cancer, could well have originated  with their use of Actos.   In many cases  these people are filing Actos bladder cancer lawsuits.   Some of these lawsuits are discovering that  the maker may have been aware of higher bladder cancer risks after using  Actos.   As these Actos bladder cancer lawsuits progress  and other lawsuits are filed, more information will undoubtedly be uncovered.   In almost every case where a drug has been  found to be dangerous, the company that produced and marketed the drug always  knew about the dangers well before the public and patients using the drug.  Will that be the case with Actos bladder  cancer?